Syk Inhibition Induces Platelet Dependent Peri-islet Hemorrhage in the Rat Pancreas (original) (raw)

Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases

Ömer Nuri Pamuk

Arthritis Research & Therapy, 2010

View PDFchevron_right

An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis

Mark Genovese

… England Journal of …, 2010

View PDFchevron_right

Inhibitors of switch kinase ‘spleen tyrosine kinase’ in inflammation and immune-mediated disorders: A review

Om Silakari

European Journal of Medicinal Chemistry, 2013

View PDFchevron_right

Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?

Seng-Lai Tan

Future Medicinal Chemistry, 2014

View PDFchevron_right

Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy

Theresa Truitt, Christine Lukacs

Arthritis Research & Therapy, 2013

View PDFchevron_right

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

Alan Lazarus

Blood, 2009

View PDFchevron_right

Kinetic assay for characterization of spleen tyrosine kinase activity and inhibition with recombinant kinase and crude cell lysates

Augustin Amour

Analytical Biochemistry, 2009

View PDFchevron_right

A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism

An Chi

Journal of Biological Chemistry, 2019

View PDFchevron_right

Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus‐prone mice

Rena Bahjat

Arthritis & Rheumatism, 2010

View PDFchevron_right

Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis

anjali pandey

Journal of Pharmacology and Experimental Therapeutics, 2011

View PDFchevron_right

The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice

Andreas Zirlik

Arteriosclerosis, Thrombosis, and Vascular Biology, 2011

View PDFchevron_right

Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial

Ruben Vargas

Arthritis and Rheumatism, 2008

View PDFchevron_right

A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models

Eunkyeong Jang

Clinical and Experimental Immunology

View PDFchevron_right

Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor

alex skone

Bioorganic & Medicinal Chemistry Letters, 2011

View PDFchevron_right

Characterization of the Mechanism of Action of Lanraplenib, a Novel Spleen Tyrosine Kinase Inhibitor, in Models of Lupus Nephritis

David Newstrom

2020

View PDFchevron_right

Development of a Pharmacodynamic Assay Based on PLC 2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)-Bruton's Tyrosine Kinase (BTK) Signaling

Seng-Lai Tan

Journal of Biomolecular Screening, 2013

View PDFchevron_right

Spleen Tyrosine Kinase Inhibition Attenuates Autoantibody Production and Reverses Experimental Autoimmune GN

Jennifer S. Smith

Journal of the American Society of Nephrology, 2014

View PDFchevron_right

Basic Science for the Clinician 48: Tyrosine Kinases in Disease

Leonard Sigal

Jcr-journal of Clinical Rheumatology, 2008

View PDFchevron_right

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents

Julie Dicarlo, Charles Peterfy

Arthritis & Rheumatism, 2011

View PDFchevron_right

Distinct pathways regulate Syk activation downstream of ITAM and hemITAM receptors in platelets

Victor Wang

View PDFchevron_right

PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model

anjali pandey

Blood, 2011

View PDFchevron_right

The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity

michael welsh

Biochemical Journal, 2004

View PDFchevron_right

Tyrosine Phosphorylation on Spleen Tyrosine Kinase (Syk) Is Differentially Regulated in Human and Murine Platelets by Protein Kinase C Isoforms

Alexander Tsygankov

Journal of Biological Chemistry, 2013

View PDFchevron_right

Critical role for Syk in responses to vascular injury

Sahil A Parikh

Blood, 2011

View PDFchevron_right